Atlas Clinical Research announced the addition of Suburban Research Associates to its site network, marking the second clinical research site partnership for the platform. Atlas previously formed a strategic partnership with Rochester Clinical Research in April 2023.
Specializing in psychiatric research, Suburban will seek to expand its research impact and leverage Atlas’ site connectivity to better serve trial patients.
According to data captured in the LevinPro HC database, this transaction represents the 14th clinical trials acquisition of 2023.
Founded in 1999 by Dr. Shivkumar Hatti, Suburban Research Associates is a clinical research site conducting psychiatric research from its two locations in Media and West Chester, Pennsylvania. Suburban has conducted more than 250 clinical research studies since inception.
Atlas Clinical Research is a therapeutically driven clinical site network built on centralized process excellence and integrated technology. Atlas Clinical Research was launched by healthcare private equity investor BPOC in April 2023. Atlas specializes in infectious disease, CNS, gastroenterology and internal medicine.
Cindric & Associates served as financial advisor and Kleinbard LLC served as legal counsel to Suburban Research Associates in connection with the transaction. Three Twenty-One Capital Partners LLC served as financial advisor and Paul Hastings LLP served as legal counsel to Atlas. Debt financing was provided by Oxford Finance LLC. Financial terms of the deal were not disclosed.
